Humoral responses after inactivated COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infection: A prospective cohort studyArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome antibody asymptomatic infections benefit blood sample booster dose Clinical severity collected coronavirus coronavirus disease COVID-19 COVID-19 vaccination detectable dose evaluated Evidence first dose humoral humoral immune response Humoral immunity Humoral response inactivated Inactivated COVID-19 vaccine individual individuals infected individuals Infection median mild cases moderate multicenter NAb titer NAbs naïve individual naïve individuals natural infection Neutralizing Neutralizing activity neutralizing antibody omicron pan-immunoglobulins. participant prospective cohort study Protein receive recovered patient SARS-CoV-2 second dose seroconversion rate severity significantly single dose single vaccine the vaccine U/mL vaccination variant [DOI] 10.1002/jmv.28055 PMC 바로가기
Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational studyObservational Study Published on 2022-09-022022-10-05 Journal: PLoS ONE [Category] SARS, 임상, 진단, [키워드] adverse event Anaphylactic reaction antibody BNT162b2 combination therapy COVID-19 COVID-19 pandemic dose Efficacy and safety eligible patient evaluate evaluated event geometric group Health immunosuppressive indicated Inflammatory bowel disease Local majority MONITOR Patient patients Prospective prospective observational study SARS-CoV-2 SARS-CoV-2 IgG antibody SARS-CoV-2 vaccination significant difference therapy treated U/mL vaccination vaccination against COVID-19 Vaccine vaccine administration [DOI] 10.1371/journal.pone.0273612 PMC 바로가기 [Article Type] Observational Study
Improved immunogenicity following the third dose of BNT162b2 mRNA vaccine in heart transplant recipientsArticle Published on 2022-09-022022-11-15 Journal: European journal of cardio-thoracic surgery : official journal of the [Category] 진단, 치료제, [키워드] acute respiratory syndrome age Anti-spike association baseline BNT162b2 BNT162b2 vaccine booster coronavirus COVID-19 decrease dose General population heart Heart transplantation immunogenicity Immunoglobulin Improved inhibitor inhibitors IQR lack mammalian median age mRNA vaccine non-responder of BNT162b2 oral steroid Patient positive predictor proportion prospective cohort study Rapamycin recipient recipients Responder seropositive Serum level severe acute respiratory syndrome coronavirus 2 significantly significantly increased the median third dose titre U/mL Vaccine [DOI] 10.1093/ejcts/ezac145 PMC 바로가기
Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter studyArticle Published on 2022-09-012022-11-15 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI Acetate anti-CD20 antibody Asymptomatic B-cell Course Disease-modifying therapy expected fumarate group healthy healthy control Heterologous homologous humoral Humoral response immune response Interferon-beta mAb majority median Mild multicenter Multiple multiple sclerosis Patient patients Probability Protective reached receiving reduced reported revaccination SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection Seroconversion significantly significantly lower study enrollment therapy Third U/mL vaccination was measured while [DOI] 10.1016/j.msard.2022.104009 PMC 바로가기
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population일본 인구에서 오미크론 변이체 중화에 대한 BNT162b2 백신 3차 접종의 효과Article Published on 2022-09-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acquired immunity Anti-receptor binding domain antibody anti-SARS-CoV-2 antibody binding domain BNT162b2 BNT162b2 vaccine booster booster vaccination collected contribute COVID-19 case COVID-19 cases declines Delta dose Efficacy elevated evaluated event fatigue Fever healthcare worker Healthcare workers humoral Humoral immunity Immunity individual Japanese Local local swelling median myalgia neutralization Neutralizing Neutralizing activity neutralizing antibody of BNT162b2 omicron Omicron variant Pfizer promotion provide Pseudotyped viruses Questionnaires reduced SARS-CoV-2 second dose sera serum sample serum samples Side effect Side effects significantly swelling Toyama U/mL university vaccination Vaccine variant variants was measured Waves wild-type [DOI] 10.1016/j.jiac.2022.05.009 PMC 바로가기 [Article Type] Article
Effects of cardiopulmonary bypass on immunoglobulin G antibody titres after SARS-CoV2 vaccinationObservational Study Published on 2022-08-032022-10-05 Journal: Interactive cardiovascular and thoracic surgery [Category] SARS, 임상, 진단, [키워드] acute respiratory syndrome antibody Antibody titre BNT162b2 calculated Cardiopulmonary cardiopulmonary bypass cardiovascular disease coronavirus Coronavirus disease 2019 decrease disease Effect effective group IgG IgG antibody Immunoglobulin Infection investigated Moderna mRNA vaccine mRNA-1273 Patient Pfizer/BioNTech preoperative preserved prospective observational study required SARS-CoV2 severe acute respiratory syndrome coronavirus 2 significantly significantly lower surgical the receptor-binding domain titre U/mL vaccination vaccination schedule Vaccine was measured while [DOI] 10.1093/icvts/ivac123 PMC 바로가기 [Article Type] Observational Study
Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients폐 이식 환자에서 2차 및 3차 SARS-CoV-2 백신에 따른 혈청학적 소견Article Published on 2022-08-012022-09-12 Journal: Immunity, Inflammation and Disease [Category] SARS, 진단, [키워드] acute respiratory syndrome age antibody Antibody titer average BBIBP-CorV booster Booster vaccine ChAdOx1 Clinical data coronavirus coronavirus disease COVID COVID-19 died difference dose doses effective enrolled evaluated had no highest ICU IgG immunization Immunocompromised patients Immunoglobulin Immunological response induce Infection injection intensive care lung transplant median men Messenger RNA mRNA mRNA vaccine mRNA-1273 mRNA-based non-mRNA vaccine pandemic Patient patients positive recipient SARS-CoV-2 SARS-CoV-2 vaccine second dose serology Serum level significantly higher STABLE Support therapy third vaccination Transplant U/mL Vaccine was measured were given [DOI] 10.1002/iid3.646 PMC 바로가기 [Article Type] Article
Temporal trends and differences of SARS-CoV-2-specific antibody responses in symptomatic and asymptomatic subjects: a longitudinal study from Umbria in Italy증상이 있는 대상과 무증상 대상에서 SARS-CoV-2 특이 항체 반응의 시간적 경향과 차이점: 이탈리아 Umbria의 종단 연구Article Published on 2022-07-182022-09-11 Journal: BMJ Open [Category] COVID19(2023년), MERS, SARS, 진단, 치료법, [키워드] anti-S anti-S antibody antibody Antibody Response Antibody responses Antibody titre antibody titres Asymptomatic Clinical severity clinically Cohort correlation COVID-19 Decline Diagnosis discharged Dynamics eligible first visit Follow-up follow-up study group hospital Immunity immunology Infectious diseases Italy longitudinal overtime participant Participants PCR test persistence positive Protein recruited reduced Reinfection remained SARS-CoV-2 SARS-COV-2 infection serological Serological testing significant difference significantly higher Signs and symptoms spike Spike proteins subject subjects Symptom symptomatic symptomatic and asymptomatic Temporal the median three group three groups threshold titre titres Treatment two groups U/mL Variation Virology while without symptom [DOI] 10.1136/bmjopen-2021-056370 PMC 바로가기 [Article Type] Article
Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study한국 성인에서 Ad26.COV2.S의 면역원성과 반응성: 전향적 코호트 연구Article Published on 2022-07-112022-09-11 Journal: Journal of Korean medical science [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Ad26 Ad26.COV2.S Adenovirus Adenovirus Vector Adverse adverse event adverse events AEs anti-S IgG Anti-spike baseline cellular immunity conducted coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 decrease Delta Dilution enrolled enzyme enzyme-linked immunospot assay evaluated fatigue Fever followed by geometric mean geometric mean titers GMT GMTs GRADE Humoral immunity IgG antibody immunogenic immunogenicity injection site pain interferon interferon-γ Korean mononuclear cell MOST myalgia NAb titer Neutralizing Neutralizing activity neutralizing antibody responses omicron Omicron variant Omicron variants outcome pandemic participant Peripheral blood Prospective prospective cohort study resolved respiratory Safe SARS-CoV-2 serious AEs severe acute respiratory syndrome Coronavirus Single-dose South Korea T-cell immunity T-cell Response T-cell responses the median U/mL university hospital vaccination Vaccines variant variants Viral Viral variants waning immunity wild-type WT SARS-CoV-2 [DOI] 10.3346/jkms.2022.37.e210 PMC 바로가기 [Article Type] Article
Low antispike antibody levels correlate with poor outcomes in COVID-19 breakthrough hospitalizations낮은 안티스파이크 항체 수준은 COVID-19 획기적인 입원의 나쁜 결과와 상관관계가 있습니다Article Published on 2022-07-012022-09-11 Journal: Journal of internal medicine [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] 1:1 Analysis analyzed antibody Antibody titer Antibody titers antispike antibodies Chain Reaction Comorbidity confounders correlation COVID-19 cut-off value Delta delta variant hospital Hospitalization Hospitalized hospitalized patient ICU ICU care immunization immunization programs Indicator intensive care intensive care unit LOS Mayo Clinic mechanical ventilation median Mortality Older outcome Patient patients polymerase chain polymerase chain reaction poor prognosis positive propensity score matching recipient replacement retrospective cohort study risk factor SARS-CoV-2 SARS-CoV-2 spike protein significantly solid organ solid organ transplant Spike protein U/mL vaccination Vaccination Status Vaccine Vaccine breakthrough variant while with COVID-19 [DOI] 10.1111/joim.13471 PMC 바로가기 [Article Type] Article